<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Biotechnology</title>
<link rel="self" type="application/atom+xml" title="Biotechnology" href="http://www.feeddistiller.com/blogs/Biotechnology/atom.xml"/>
<link rel="alternate" type="application/atom+rss" title="Biotechnology" href="http://www.feeddistiller.com/blogs/Biotechnology/feed.rss"/>
<subtitle>items about biotechnology</subtitle>
<feedid>251</feedid>
<feedname>Biotechnology</feedname>
<updated>2010-09-03T02:54:23</updated>
<author>
<name>Science Guy</name>
<email>barry.david.adams@gmail.com</email>
</author>

<entry>
<from href="http://www.biohealthinvestor.com/feed/rss">BioHealth Investor</from>
<title>Intendis Enters Deal With Kythera For Fat-Reduction Drug</title>
<link href="http://biohealthinvestor.com/2010/09/intendis-enters-deal-with-kythera-for-fat-reduction-drug.html"/>
<updated>2010-09-03T02:52:29</updated>
<summary>Intendis, Bayer Healthcare&amp;#8217;s dermatology sector, has signed a deal with Los Angeles-based biopharma company Kythera Biopharmaceuticals in which the company receives rights to Kythera&amp;#8217;s lead product candidate, ATX-101, in areas outside of the United States and Canada.  Kythera, in return, will receive $43 million upfront and up to $330 million beyond their initial payment.  ATX-101 is used [...]</summary>
<id>fe18e9c9912f316a8eaa56cdf8a8008d</id>
</entry>

<entry>
<from href="http://www.biohealthinvestor.com/feed/rss">BioHealth Investor</from>
<title>Inhibitex Completes Trial For Hep C Drug</title>
<link href="http://biohealthinvestor.com/2010/09/3289.html"/>
<updated>2010-09-03T02:52:29</updated>
<summary>Inhibitex Inc. (NASDAQ: INHX) was up $0.16 (11.27%) this morning to $1.58 on news that the company had completed a Phase1a, single ascending dose trial of its nucleotide polymerase inhibitor, INX-189.  The drug is currently being developed for the treatment of chronic hepatitis C.  Tests of the drug have, at this point, been positive with [...]</summary>
<id>b223d84beb1b5ebd3d215d57cbfcec98</id>
</entry>

<entry>
<from href="http://www.biohealthinvestor.com/feed/rss">BioHealth Investor</from>
<title>Roche Cancer Drug Does Not Receive FDA Approval</title>
<link href="http://biohealthinvestor.com/2010/08/roche-cancer-drug-does-not-receive-fda-approval.html"/>
<updated>2010-09-03T02:52:29</updated>
<summary>Swiss drugmaker Roche took a blow this past Friday after the U.S. FDA denied the company&amp;#8217;s request for accelerated approval regarding trastuzumab-DM1, or T-DM1.  The drug, according to Reuters, &amp;#8220;comprises ImmunoGen&amp;#8217;s DM1 cancer-cell-killing agent linked to the HER2-targeting antibody trastuzumab, or Herceptin,&amp;#8221; as a means of combating cancer.  The FDA&amp;#8217;s decision will now setback the [...]</summary>
<id>2979452a0eab251554cbea3b9daa1cf6</id>
</entry>

<entry>
<from href="http://www.biohealthinvestor.com/feed/rss">BioHealth Investor</from>
<title>Pluristem Placental Cells Found Effective For Several Treatments</title>
<link href="http://biohealthinvestor.com/2010/08/pluristem-placental-cells-found-effective-for-several-treatments.html"/>
<updated>2010-09-03T02:52:29</updated>
<summary>Pluristem Therapeutics, Inc. (NASDAQ: PSTI) is up 12.87% this morning after it announced that its PLX therapeutic stem cell line, derived from the material of a human placenta, would be the only type of cell selected for a study designed to prevent inflammatory heart disease, also called diastolic heart failure. Shares of PSTI is up [...]</summary>
<id>3e0c246bce8280ad32b506f03d1c35f0</id>
</entry>

<entry>
<from href="http://www.biohealthinvestor.com/feed/rss">BioHealth Investor</from>
<title>AVEO Discovers Potential Cancer Breakthrough</title>
<link href="http://biohealthinvestor.com/2010/08/aveo-discovers-potential-cancer-breakthrough.html"/>
<updated>2010-09-03T02:52:29</updated>
<summary>AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) was up $0.75 (9.14%) this morning to $8.96 following reports that by introducing an experimental drug during chemotherapy the company had succeeded to wipe out brain cancer cells in mice.  This news provides hope for a new treatment for the disease in humans, and testing in humans has already begun. [...]</summary>
<id>2b34b37cf36e4bc9bde53588eeffece5</id>
</entry>

<entry>
<from href="http://sdbn.org/feed/">San Diego Biotechnology Network: Biotech Events, Jobs, News, Companies, Directory, Blog, &amp; Calendar</from>
<title>Otonomy Gets $38.5M, Avalon Helps Restart Drug for Age-Related Blindness, Accumetrics Heads Toward Profitability, &amp; More San Diego Life Sciences News</title>
<link href="http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/QaBquoxSO9Q/"/>
<updated>2010-09-02T12:40:23</updated>
<summary>The life sciences news over the past week was almost all about deals. Money came out of INC Research, a contract research organization in North Carolina that was founded in San Diego. Money went into...

[[Click headline to continue reading.]]</summary>
<id>a6f6651c988a88cae006c4d6b02247e7</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>Drought Tolerant Crops Critical to Increasing Food Production</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/Y7QZBGZwsjk/"/>
<updated>2010-08-26T17:20:32</updated>
<image href="http://blogs.das.psu.edu/tetherton/wp-content/uploads/drought-resistant-corn-ver-2-300x201.png" width="150" height="100"/>
<summary>Terry D. Etherton


Increasing agriculture productivity to meet growing global demand for   food must be accompanied by an intense, innovative effort to enhance  the  environmental imprint of farming to be sustainable.
“We face the daunting challenge of nearly doubling agriculture   production to meet the demands of the estimated 9 billion people [...]</summary>
<id>a7eb28119333df5a755d3e7fb2c778ca</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>Egg Quality Assurance Programs and Salmonella</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/nQ25bJVzcFI/"/>
<updated>2010-08-26T17:19:15</updated>
<image href="http://blogs.das.psu.edu/tetherton/wp-content/uploads/egg-300x205.jpg" width="150" height="98"/>
<summary>Paul Patterson
Professor of Poultry Science 
Penn State University

For those readers who have been following the news about eggs and salmonella, here is a very informative  Op-Ed article written by Dr. Patterson that was published online in the New York Times on  August 25.
##
The American  food system, and in particular egg producers in [...]</summary>
<id>8f8fc6d4302d97c798aa21ae729b1a13</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>Italian Farmer Pushes Genetically Modified Crops</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/ASxnnYWt_8g/"/>
<updated>2010-08-26T17:15:42</updated>
<summary>By COLLEEN BARRY
Bloomberg Business Week
August 18, 2010
PORDENONE, Italy
Giorgio Fidenato has made a habit of carrying a raw ear of yellow corn and taking a hearty bite whenever a camera is in sight.
It&amp;#8217;s a provocation. The Italian farmer&amp;#8217;s corn is genetically   modified, grown surreptitiously in fields in the northeast not far from   [...]</summary>
<id>70128bf9fe7b9a826d0e707efced82e8</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>Are Organic Foods Over-Hyped?</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/cbtq70F5MNE/"/>
<updated>2010-08-26T17:14:12</updated>
<image href="http://blogs.das.psu.edu/tetherton/wp-content/uploads/Gourmet-Food-300x275.png" width="150" height="136"/>
<summary>Virginia Ishler
Dairy Complex Manager
Department of Dairy and Animal Science
Penn State University

News media has a tendency to portray certain aspects of agricultural  production either positively or negatively. Doug Powell, an associate  professor of food safety at Kansas State University co-authored a paper on “Coverage  of organic agriculture in North American newspapers: Media – [...]</summary>
<id>5d02a80396cf6c915cf13331a0077016</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>“Big Ag” Wins Kudos for Being “Green”</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/oUWuiIiGraE/"/>
<updated>2010-08-26T17:02:02</updated>
<image href="http://blogs.das.psu.edu/tetherton/wp-content/uploads/Turbines-Corn-Field-300x200.png" width="150" height="100"/>
<summary>Terry D. Etherton

Scientists at Stanford University  have published provocative new findings that agriculture’s &amp;#8220;Green Revolution&amp;#8221;  has greatly reduced forest clear-cutting and resulting  climate-warming  emissions.  This is a remarkable (but not unexpected) benefit of  contemporary production agriculture, and the application of technologies  (and biotechnologies) that have boosted efficiency of food [...]</summary>
<id>c9ccdd6c51eea77962d8dbdafccfd108</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>EU Ban Could Spark Cloned Animal Trade Dispute</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/JGd7x1B5P2g/"/>
<updated>2010-08-26T17:00:15</updated>
<image href="http://blogs.das.psu.edu/tetherton/wp-content/uploads/Cloned-Calves1-300x223.png" width="150" height="111"/>
<summary>Terry D. Etherton

I never cease to be amazed at the political process in Europe that  keeps hindering adoption of safe and effective ag biotechnologies.  The  latest folly occurred on July 7, 2010 when Members of the European   Parliament (MEP) renewed their appeal for a ban on food from cloned  animals [...]</summary>
<id>1b9b903807621787e94618bce1a4ceb3</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>Farmers in Europe Demand Fairer Access to GM Crops</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/90wpfKDB8OA/"/>
<updated>2010-08-26T16:58:35</updated>
<summary>Terry D. Etherton
An interesting news release from Europe came across my desk.  A group  of farmers from Spain, Portugal and Romania traveled to Brussels,  Belgium to convey to the European Commission that they are upset that  they can not us genetically modified (GM) crops.  They urged that laws  be passed to [...]</summary>
<id>742f73fb6aacdc7cf16c0d6697e516d4</id>
</entry>

<entry>
<from href="http://feeds.feedburner.com/terry-etherton?format=xml">Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</from>
<title>DAIRY INDUSTRY DRAWS ANIMAL WELFARE TARGET ON ITS OWN BACK</title>
<link href="http://feedproxy.google.com/~r/terry-etherton/~3/AqexCj017HU/"/>
<updated>2010-08-26T16:55:13</updated>
<summary>Chad Dechow
Associate Professor, Dairy Cattle Genetics
Department of Dairy and Animal Science
The Pennsylvania State University
Several high profile undercover videos of animal abuse on dairy farms  have increased the pressure to implement welfare guidelines, much like  the United Egg Producers’ certification program. We’re all appalled with  what we have seen in some videos, and [...]</summary>
<id>ead2178bd7faba91438d6023d33cf3ab</id>
</entry>

<entry>
<from href="http://www.medworm.com/rss/medicalfeeds/tags/biotechnology.xml">MedWorm Tags: biotechnology</from>
<title>Improved Vision From New Eye Procedure</title>
<link href="http://www.medworm.com/index.php?rid=3868778&amp;cid=t_92087_107_f&amp;fid=36584&amp;url=http%3A%2F%2Fwww.biotech-weblog.com%2F50226711%2Fimproved_vision_from_new_eye_procedure.php"/>
<updated>2010-08-15T22:22:12</updated>
<summary>Â© FeatheredTarToday, most people are aware of the benefits of Lasik eye surgery for the treatment of an eyesight condition better known as double vision. However, there is a new procedure called laser blended vision surgery. 
 
Lasik eye surgery became a popular treatment procedure because of its success in treating the eye&amp;#39;s difficulty in focusing up-close objects. This is done by correcting the vision of one eye for distance while the other, for close vision. What is not covered by Lasik however, is the ... (Source: The Biotech Weblog)</summary>
<id>0c4430a527e2f4cf8574e9f9954be4ac</id>
</entry>

<source>
<title>Terry Etherton&apos;s Blog on Hormones, Biotechnology, and Food Safety</title>
<link href="http://feeds.feedburner.com/terry-etherton?format=xml"/>
<count>8</count>
</source>

<source>
<title>BioHealth Investor</title>
<link href="http://www.biohealthinvestor.com/feed/rss"/>
<count>5</count>
</source>

<source>
<title>MedWorm Tags: biotechnology</title>
<link href="http://www.medworm.com/rss/medicalfeeds/tags/biotechnology.xml"/>
<count>1</count>
</source>

<source>
<title>San Diego Biotechnology Network: Biotech Events, Jobs, News, Companies, Directory, Blog, &amp; Calendar</title>
<link href="http://sdbn.org/feed/"/>
<count>1</count>
</source>

</feed>
